Achievements
- Y Combinator S20 alum and founder of Pardes Biosciences
- Led Assembly Biosciences as Chief Medical Officer, raising over $300M for hepatitis B therapies
- Founded Pardes Biosciences, developing oral antivirals for COVID-19 and other viruses
- Held leadership roles at Gilead, Roche, and Merck, with research experience at NIH/NIAID
- Advised biotech startups as a Y Combinator visiting group partner
- Holds a biology degree from Cornell and an MD from UMDNJ, with additional training at UW, NYU, and NIH
Can't sleep on Uri Lopatin
Let’s dive into the world of Uri Lopatin – this guy’s the real deal in biotech, and his story is just wild. So, he’s a YC S20 alum – jumped into the startup scene pretty recently but already crushed it. Before that, Uri was all over the place, working at some heavy hitters like Gilead, Roche, Merck, and even doing research at NIH/NIAID. Dude’s got legit creds in the science world, with a biology degree from Cornell and an MD from UMDNJ, plus bits of training at UW, NYU, and NIH. Basically, he’s been deep in the trenches of biotech and pharma from every angle.
But here’s where it gets interesting. Uri wasn’t just a scientist or a doctor; he’s a builder. He founded Assembly Biosciences, where he was Chief Medical Officer, and he led the charge on developing new therapies for hepatitis B – raised over $300M for clinical stuff. That’s no small feat. He’s someone who’s been in the weeds, pushing new meds through the pipeline, and raising serious cash along the way.
Then, he jumped into the startup world with Pardes Biosciences – this is the one that really put him on the map. Pardes is all about fighting viruses, especially COVID, with oral antivirals. Think about it – this guy saw a global mess, knew his stuff, and decided to build something that could actually make a difference. Pardes was part of YC S20, which is a huge stamp of approval – shows he’s not just talk, he’s got the skills and the vision to back it up.
Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.
Talk to herWhat does his process say about him? It’s pretty clear – Uri’s all about tackling big health problems. He’s driven by a deep motivator: making real impact. His experience at pharma giants and NIH gave him the technical chops; founding and leading startups shows he’s got the guts and grit to turn science into real-world solutions. Dude’s not just in this for the fame or cash – he genuinely cares about fighting viruses and saving lives.
Bottom line? Uri Lopatin’s the kind of guy who’s been around the block, learned from the best, and then jumped into the startup game to actually do something meaningful. He’s a mix of scientist, builder, and fighter, and honestly, the biotech world needs more folks like him who aren’t afraid to get their hands dirty and go after the big problems. No cap – this guy’s an inspiration, and I’d keep an eye on whatever he’s building next.

Select your comment type:
If something is wrong about Uri Lopatin, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)